Summary

Prohibits the National Institutes of Health (NIH) from awarding grants, contracts, cooperative agreements, or technical assistance to support research that uses live animals unless the animal research occurs within the United States (including states, DC, and U.S. territories). It also updates internal statutory cross-references and records findings that NIH funded about $2.2 billion to foreign organizations for animal research from FY2011–FY2021 and that current oversight of foreign animal research relies on self-reporting. The measure does not set new dollar amounts or deadlines; it simply adds a statutory prohibition on funding animal research performed outside U.S. jurisdiction and makes minor statutory reorganization to accommodate the new rule.

Key Points

• Bans NIH support for any research using live animals unless the animal work takes place in the United States (states, DC, territories).
• Covers all NIH support types: grants, contracts, cooperative agreements, and technical assistance.
• Adds a new statutory prohibition and reorganizes existing subsections to update cross-references.
• Finds NIH funded about $2.2 billion to foreign entities for animal research from FY2011–FY2021 and that oversight of foreign animal facilities is limited.
• Does not specify funding amounts, transition timelines, waivers, or enforcement details in the statutory text provided.
• Would block NIH funding to foreign institutions for animal-based studies and require NIH to refuse or modify awards for such projects.
• Aims to address concerns about animal welfare oversight for research performed outside U.S. jurisdiction.
• Could affect international collaborations, safety/ethics monitoring, and where preclinical animal work is conducted.

Categories & Tags